Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 31, Number 12—December 2025
Dispatch
Case of Congenital Tularemia with Neuroinvasive Disease, Utah, USA
Table 1
Pertinent results of laboratory tests taken during hospitalization of infant in case of congenital tularemia with neuroinvasive disease, Utah, USA*
| Test | Hospitalization 1 |
Hospitalization 2 |
||
|---|---|---|---|---|
| Admission: DOL 16 | Discharge: DOL 21 | Admission: DOL 30 | ||
| Complete blood count | ||||
| Hemoglobin, K/μL | 13.8 | 12.6 | 13.1 | |
| Hematocrit, g/dL | 39.8 | 36.7 | 39.6 | |
| Leukocyte, K/μL | 56.8 | 17.6 | 25.2 | |
| Neutrophils, K/μL | 29.0 | 3.3 | 4.8 | |
| Lymphocytes, K/μL | 19.9 | 11.3 | 15.4 | |
| Monocytes, K/μL | 4.5 | 3.0 | 3.5 | |
| Platelets, K/μL |
206 |
149 |
584 |
|
| Chemistry | ||||
| Sodium, mmol/L | 129 | 144 | 137 | |
| Total bilirubin, mg/dL | 1.3 | 1.1 | 0.9 | |
| ALP, unit/L | 205 | 139 | 335 | |
| AST, unit/L | 898 | 144 | 57 | |
| ALT, unit/L | 316 | 96 | 26 | |
| Lactic acid, mmol/L |
2.4 |
1.8 |
||
| Inflammatory/infectious markers | ||||
| C-reactive protein, mg/dL | 17.1 | 6.8 | 4.7 | |
| Procalcitonin, ng/mL |
3.02 |
0.15 |
||
| Cerebrospinal fluid | ||||
| Glucose, mg/dL | 44 | NA | 36 | |
| Total protein, mg/dL | 114 | NA | 81 | |
| Leukocytes, cells/μL | 48 | NA | 31 | |
| Neutrophils, % | 3 | NA | 4 | |
| Lymphocytes, % | 81 | NA | 71 | |
| Monocytes, % | 16 | NA | 25 | |
| Erythrocytes, cells/μL | <1 | NA | 7 | |
| Gram stain |
Negative |
NA |
Negative |
|
| BioFire Respiratory 2.1 panel |
Positive for rhinovirus |
Positive for rhinovirus |
||
| Cultures | ||||
| Blood | No growth × 5 d | NA | No growth × 5 d | |
| Urine | 1,000 colony-forming units of Staphylococcus lugdunensis | NA | No growth × 2 d | |
| CSF | No growth × 4 d | NA | No growth × 4 d | |
*Abnormal values in bold. ALP, alkaline phosphatase; ALT, alanine transaminase; AST, aspartate aminotransferase; DOL, day of life; NA, not applicable.
Page created: November 18, 2025
Page updated: December 12, 2025
Page reviewed: December 12, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.